ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03405454
Brief Title: A Multicentre Phase II Trial of Durvalumab Versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinomas

First Submitted : October 19, 2017
First Submitted that Met QC Criteria : January 19, 2018
First Posted : January 23, 2018

Last Update Submitted that Met QC Criteria : May 16, 2018
Last Update Posted : May 18, 2018